Men der opstår problemer, når labile bestanddele, f.eks. røde blodlegemer, blodplader eller ikke-fraktioneret plasma, hindres i at blive udvekslet med andre medlemsstater.
But the difficulty arises when labile components, for example red blood cells, platelets or plasma prior to fractionation, are prevented from being shared with other Member States.